ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Kempen Orange Fund Nv

Kempen Orange Fund Nv (KORAF)

120.30
1.65
(1.39%)
Cerrado 04 Enero 10:30AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
120.30
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
562
120.30 Rango del Día 120.30
114.20 Rango de 52 semanas 136.36
Precio Anterior
118.65
Precio de Apertura
120.30
Última hora de negociación
Volumen promedio (3 m)
2,838
Volumen financiero
-
Precio Promedio Ponderado
-

KORAF Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
12.131.8024879411118.17120.3117.621173118.24185888DE
4-1.67-1.36918914487121.97123.171171596119.19030073DE
12-2.35-1.91602119853122.65123.17116.622838120.62129883DE
26-0.2-0.165975103734120.5124.13114.23641120.8264276DE
52-6.42-5.06628787879126.72136.36114.22899123.2243114DE
156-18.12-13.0905938448138.42141.88101.91708123.2128685DE
2602121.148036253899.3141.8864.281890114.66859132DE

KORAF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Kempen Orange Fund Nv?
El precio actual de las acciones de Kempen Orange Fund Nv es 120.30 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Kempen Orange Fund Nv?
Kempen Orange Fund Nv ha negociado en un rango de 114.20 € a 136.36 € durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M
Steady_T Steady_T 4 minutos hace
All in all that is a pretty good critique. Those are all points that the regulators will look at. I would say that the various blood chemistry measures that were called biomarker endpoints by chat GPT were in the other outcome measures section of the trial. They were not called endpoints but are sim
AVXL
manibiotech manibiotech 5 minutos hace
Because you don't have any other choice ...
NWBO
slops slops 5 minutos hace
A good PR = A good run most always
VDRM
Risk vs Reward Risk vs Reward 6 minutos hace
You assumed because I wasn't posting that I sold out. Was calling KULR 2025 stock of the year than vanished. This is my last ever post to you. Ignore 
KULR
NoMoDo NoMoDo 6 minutos hace
I think Jerry has a really good voice tho... for sure:
https://www.youtube.com/watch?v=lRs1iLzHV0Q
HMBL
Monksdream Monksdream 6 minutos hace
FATE, under $2
https://investorshub.advfn.com/uimage/uploads/2025/1/4/zjkkgIMG_4427.gif
xodcode xodcode 8 minutos hace
Blarcamesine's favorable comparative performance to Donanemab is yet another indicator of EMA approval for Blarcamesine.

The stars are aligning nicely for Blarcamesine EMA approval!
AVXL
sharkey1 sharkey1 8 minutos hace
You may be right jour, but the old one still works just fine,

CANT WAIT TILL FEB 14 CC
ELTP
Signor Signor 8 minutos hace
Would like to RNVA do a test run like INQR did the other week and stay there while Seamus keeps working.
INQR RNVA
martyDg martyDg 8 minutos hace
You will probably hold this for 5 years, not because of the big return, but because you're stuck and can't get out without incurring losses.
NWBO
Ace Trader Ace Trader 8 minutos hace
CAT MANS at it again https://x.com/MarkCalabria/status/1874940336424075438

Lucky theres people calling him out !
https://x.com/timpagliara/status/1875163714628030648
FNMA
jimr1717 jimr1717 9 minutos hace
Fear not, once the massive S1 share selling gets approved the shares will be plentiful and I suspect that they will make a Walmart Black Friday sale look pitiful.
Just get those bid orders in now and they will soon be filled.

Only Fools are Fooled
ATMH
dstock07734 dstock07734 9 minutos hace
The longs evolve as more information is available. The people who evolve will thrive with big wealth. Your buddy LC who has a flat curve of learning will become obsolete and extinct. Truth hurts!
NWBO
joyceschoice joyceschoice 9 minutos hace
Well that immediately brought to my mind the phrase. "Size doesn't matter, it's what you do with it that counts." lol!
manibiotech manibiotech 10 minutos hace
Smart = losing 90-99% value in 10 years 
Very smart indeed 
NWBO
price_and_volume price_and_volume 10 minutos hace
You didn't read his other articles?

No worries, OT anyway, same as the article you posted.

GLTA
HMBL
RSI38 RSI38 10 minutos hace
I share those feelings

We always prevail $$$$


RMTD
RMTD
surfkast surfkast 11 minutos hace
Maybe this will give us a boost.
IOVA
NoMoDo NoMoDo 11 minutos hace
The poster you responded to was criticizing the negative posting of someone who claims to have a good time bashing HMBL. I am trying to make they connection that a mod would obviously make when posting otherwise off topic info. Are you saying that there are people who claim to create a short squee
GME HMBL
jour_trader jour_trader 11 minutos hace
I thought he was moving old production line into the new facility too, but could be mistaken. 

Assuming we'll have enough Vyvanse API to cover a shift, at the following prices we have some nice revenue:

$30 per bottle: $1.7M per shift for Vyvanse
$40 per bottle:
API
dukeb dukeb 11 minutos hace
Indeed you were. There are plenty of people here perpetuating the fairy tale of riches because it will allow them to dump their shares on the rubes.
Other than that, there is more than enough outright stupidity to go around.

I was giving him too much credit
HMBL
jcromeenes jcromeenes 12 minutos hace
I NEVER believe the Govt won't make a stupid decision, especially out of spite. lol.
FNMA
Lime Time Lime Time 12 minutos hace
Shell badge added 1/3

Looks like its coming back soon 🚀
VVWT
Paulm1234 Paulm1234 12 minutos hace
lol sure bud 
TWOH
dstock07734 dstock07734 13 minutos hace
Did you say the longs are so gullible? I think the longs are smart people. Moreover, they are courageous in that they still held conviction in this investment back then when everything was murky. Now they are even more confident that they will rewarded enormously pretty soon.

I never
NWBO

Su Consulta Reciente

Delayed Upgrade Clock